Keith A. McLean, M.D., cardiologist, joins Norton King’s Daughters’ Health in Madison, Indiana

Norton Heart & Vascular Institute welcomes Keith A. McLean, M.D., cardiologist, to Norton King’s Daughters’ Health in Madison, Indiana. The office is located in the Norton King’s Daughters’ Health Downtown Medical Building at 630 N. […]

View more

Kevin Graham, M.D., joins Norton Heart & Vascular Institute Structural Heart Program

Kevin A. Graham, M.D., a cardiothoracic surgeon, has joined Norton Heart & Vascular Institute.  Dr. Graham, who earned his medical degree from Indiana University, Indianapolis, and completed his residency there, has been practicing in Illinois. […]

View more

Ischemic heart disease in women may not show up on standard tests

Ischemic heart disease in women can lead to a heart attack, but this risk may go unnoticed. This is because a patient’s diagnostic coronary angiogram shows “clear” arteries. “When diagnosing women for ischemic heart disease, [...]

View more

Borderline hypertension poses myocardial dysfunction risks

Borderline hypertension or subclinical hypertension is a substrate for myocardial dysfunction, and patients can go for a long time with hypertension that isn’t clinically recognized, according to a heart failure specialist at Norton Heart & […]

View more

Hypertension in women and its consequences

The risks and consequences of hypertension in women differ from those in men and change throughout women’s lifetimes. Overall, hypertension in women is less prevalent than in men until age 60 and becomes more prevalent […]

View more

Norton Heart & Vascular Institute expands Women’s Heart Program

Norton Heart & Vascular Institute launched a Women’s Heart Program in 1995. Today it has expanded to include more providers and services for a region where heart disease, especially in women, is a deadly issue. [...]

View more

CT-FFR analysis shows patient’s level of cardiac obstruction and location, guiding treatment

The patient In July 2022, a 45-year-old male with a six-year history of chest pain went to the emergency room complaining of chest discomfort and shortness of breath over the previous two weeks. He was [...]

View more

Advances in hyperlipidemia medications put cholesterol goals in reach for more patients

Diet and exercise many times are not enough to lower the risk of hyperlipidemia (HLD). As we’ve learned over the years, genetics can play the biggest role. Fortunately, we now have treatments we didn’t have […]

View more

Advanced Heart Failure Referral Guidelines

When symptoms of heart failure begin progressing or patients start decompensating, there is a brief opportunity for referral to an advanced heart failure center. The American Heart Association calls this the “golden window.” Providers should […]

View more

Mavacamten, a new treatment for hypertrophic cardiomyopathy is changing lives

A new, first-in-its-class treatment for hypertrophic cardiomyopathy, mavacamten, has been a game-changer for my patients with obstruction. In April, the Food and Drug Administration (FDA) gave breakthrough therapy designation and orphan drug designation for the […]

View more

Neurohormonal blockade in heart failure

Newly diagnosed heart failure patients have a three-month window of care crucial to their likelihood of recovery. The difference can be returning to a normal life versus awaiting a heart transplant or mechanical circulatory support […]

View more

Lauren R. Albers, M.D., joins Norton Heart & Vascular Institute to focus on women’s cardiology

Lauren R. Albers, M.D., has joined Norton Heart & Vascular Institute to focus on women’s cardiology. Dr. Albers, who completed her fellowship in cardiovascular medicine at the UofL School of Medicine, joins the Norton Heart […]

View more

Search our entire site.